JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2002) 175, 535-543       DOI: 10.1677/joe.0.1750535
© 2002 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sloboda, D.
Right arrow Articles by Challis,
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sloboda, D.
Right arrow Articles by Challis, , JR
Journal of Endocrinology, Vol 175, Issue 2, 535-543
Copyright © 2002 by Society for Endocrinology


Articles

Repeated maternal glucocorticoid administration and the developing liver in fetal sheep

DM Sloboda, JP Newnham, and Challis JR


Prenatal glucocorticoid exposure has been associated with a reduction in birth weight and postnatal alterations in glucose homeostasis and hypothalamic-pituitary-adrenal (HPA) axis function. The mechanisms underlying these responses are unknown, although changes in fetal hepatic development may play an important role. The fetal liver produces key regulators of fuel metabolism and of the developing HPA axis that are altered by glucocorticoids. The local availability of glucocorticoids is regulated, in part, by corticosteroid-binding protein (CBG), glucocorticoid receptors (GR) and by the enzyme 11beta-hydroxysteroid dehydrogenase (11betaHSD), but the effects of maternal glucocorticoid administration on the expression of these genes in the fetal liver are unknown. 11betaHSD1 is the predominant form of this enzyme present in the liver and is responsible for the conversion of cortisone to cortisol. To determine if prenatal glucocorticoid exposure alters fetal hepatic regulation of CBG, 11betaHSD1 and GRs, we treated pregnant ewes with betamethasone (0.5 mg/kg) intramuscularly at 104, 111 and 118 days of gestation (term 150 days). Animals were killed at 125 or 146 days of gestation. Maternal betamethasone administration did not alter mean cord plasma glucose but significantly decreased cord plasma insulin levels (P<0.05) at 125 days of gestation. At 146 days of gestation, cord plasma glucose levels were significantly increased without alterations in insulin levels following maternal betamethasone treatment (P<0.05). Maternal betamethasone administration resulted in a significant increase in fetal hepatic 11betaHSD1 mRNA and protein levels at 125 days of gestation (P<0.05). CBG mRNA levels were significantly elevated over control at 125 days although levels of CBG protein were not significantly different. GR protein levels were not statistically different at either 125 or 146 days of gestation following glucocorticoid administration. These data suggest that prenatal betamethasone exposure in the ovine fetus results in alterations in cord glucose and insulin levels as well as alterations in hepatic 11betaHSD1 mRNA and protein expression. These changes in 11betaHSD1 increase the potential to generate local cortisol from circulating cortisone. We speculate that this could affect expression of glucocorticoid-dependent hepatic enzymes involved with the regulation of glucose production and HPA responsiveness.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. L. Gatford, J. A. Owens, S. Li, T. J. M. Moss, J. P. Newnham, J. R. G. Challis, and D. M. Sloboda
Repeated betamethasone treatment of pregnant sheep programs persistent reductions in circulating IGF-I and IGF-binding proteins in progeny
Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E170 - E178.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. T. Lam, S. Sharma, R. S. Baker, J. Hilshorst, J. Lombardi, K. E. Clark, and P. Eghtesady
Fetal stress response to fetal cardiac surgery.
Ann. Thorac. Surg., May 1, 2008; 85(5): 1719 - 1727.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. M. Sloboda, T. J. M. Moss, S. Li, D. Doherty, I. Nitsos, J. R. G. Challis, and J. P. Newnham
Prenatal betamethasone exposure results in pituitary-adrenal hyporesponsiveness in adult sheep
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E61 - E70.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Baserga, M. A. Hale, R. A. McKnight, X. Yu, C. W. Callaway, and R. H. Lane
Uteroplacental insufficiency alters hepatic expression, phosphorylation, and activity of the glucocorticoid receptor in fetal IUGR rats
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1348 - R1353.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. M. Sloboda, T. J. M. Moss, S. Li, D. A. Doherty, I. Nitsos, J. R. G. Challis, and J. P. Newnham
Hepatic glucose regulation and metabolism in adult sheep: effects of prenatal betamethasone
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E721 - E728.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
A L Fowden and A J Forhead
Endocrine mechanisms of intrauterine programming
Reproduction, May 1, 2004; 127(5): 515 - 526.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. H. Bloomfield, M. H. Oliver, C. D. Giannoulias, P. D. Gluckman, J. E. Harding, and J. R. G. Challis
Brief Undernutrition in Late-Gestation Sheep Programs the Hypothalamic-Pituitary-Adrenal Axis in Adult Offspring
Endocrinology, July 1, 2003; 144(7): 2933 - 2940.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for Endocrinology.